ACM
ANIK icon

Aquatic Capital Management’s Anika Therapeutics ANIK Stock Holding History

Aquatic Capital Management’s Portfolio ANIK Stock Details ANIK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-2,927
Closed -$44K – 1227
2025
Q1 		$44K Buy
2,927
+349
+14% +$5.81K ﹤0.01% 1145
2024
Q4 		$42.4K Buy
+2,578
New +$50.8K ﹤0.01% 1190
2024
Q1 		– Sell
-3,700
Closed -$84K – 1201
2023
Q4 		$84K Buy
3,700
+900
+32% +$18.6K ﹤0.01% 1037
2023
Q3 		$52K Buy
2,800
+1,800
+180% +$37.3K ﹤0.01% 943
2023
Q2 		$26K Buy
+1,000
New +$26.8K ﹤0.01% 1090
2023
Q1 		– Sell
-1,800
Closed -$53K – 1237
2022
Q4 		$53K Buy
+1,800
New +$51.2K ﹤0.01% 1000

Other funds holding ANIK

TI
Trigran Investments Northbrook, Illinois $545M AUM 56.2% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
CP
Caligan Partners New York $2.13B AUM 758.65% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $1.1B AUM 197.64% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.6B AUM 109.3% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
AFA
Alta Fundamental Advisers New York $333M AUM 102.25% 1-Year Est. Return

Aquatic Capital Management's ANIK Position: Q2 2025 in Review

Aquatic Capital Management sold out of Anika Therapeutics (ANIK) in Q2 2025, closing a stake of 2,927 shares — an estimated $44K sold.

Aquatic Capital Management first reported a position in ANIK in Q4 2022 and held it in 6 quarters. The position peaked at $84K in Q4 2023. 103 funds tracked by Wall St. Rank hold ANIK as of Q2 2025.

  • Aquatic Capital Management reported no remaining Anika Therapeutics position as of Q2 2025 after selling out during the quarter.
  • Aquatic Capital Management sold 2,927 Anika Therapeutics shares in Q2 2025, an estimated $44K.
  • Aquatic Capital Management first reported a position in Anika Therapeutics in Q4 2022 and held it in 6 quarters.
  • Aquatic Capital Management's Anika Therapeutics position peaked at $84K in Q4 2023.
  • 103 funds tracked by Wall St. Rank held Anika Therapeutics as of Q2 2025.

Based on Aquatic Capital Management's 13F filing for Q2 2025, filed 14 Aug 2025.